Peplin

Quick facts

Phase 3 pipeline

• PEP005 (ingenol mebutate) Gel · Dermatology
  Ingenol mebutate activates protein kinase C (PKC) to induce rapid necrosis of actinic keratosis cells and trigger immune-mediated clearance of remaining lesions.

Phase 2 pipeline

• Lesion count · Dermatology
  Lesion count drug works by counting and tracking lesions in the body.
• PEP005 Topical Gel

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Peplin portfolio CI brief
• Peplin pipeline updates RSS